Some Tumor Cell Protein Kinases Activated by Receptors as Markers, Including Elastin Receptors

References

• O'Shaughnessy J, Moscow J A, Cowan K H. Breast cancers into the 1990s. Molecular Foundations of Oncology, S Broder. Williams & Wilkins, Baltimore 1991; 311–338
   Google Scholar
• Pantel K, Izbicki J R, Angstwurm M. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993; 53: 1027–1031
   PubMed Web of Science ®Google Scholar
• Hamdy F C, Lawry J, Anderson J B. Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol 1992; 69: 392–396
   PubMedGoogle Scholar
• Figueroa J A, Yee D, McGuire W L. Prognostic indicators in early breast cancer. Am J Med Sci 1993; 305: 176–182
   PubMed Web of Science ®Google Scholar
• Tripathy D, Benz C C. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers. Oncogenes and Tumor Suppressor Genes in Human Malignancies. Kluwer Academic Publishers, Boston 1993; 15–60
   Google Scholar
• Rinker-Schaeffer C W, Isaacs W B, Isaacs J T. Molecular and cellular markers for metastatic prostate cancer. Cancer Metabt Rev 1993; 12: 3–10
   PubMed Web of Science ®Google Scholar
• Cohen A M, Shank B, Friedrnan M A. Colorectal cancer. Cancer: Principles and Practice of Oncology, VT DeVita, Jr, S Hellman, S A Rosenberg. JB Lippincott, Philadelphia 1989; 895–964
   Google Scholar
• Baum M. The curability of breast cancer. Breast Cancer Management, BA Stall. Heinemann, London 1997; 3–13
   Google Scholar
• Hosino M, Saga T, Sakahara H. Construction of immunoradiometric assay for circulating c-erbB-2 proto-oncogene product in advanced breast cancer patients. Jpn J Cancer Res 1993; 84: 147–152
   PubMedGoogle Scholar
• Hynes N E. Amplification and overexpression of the erbB-2 gene in human tumors: Its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Cancer Biol 1993; 4: 19–26
   PubMed Web of Science ®Google Scholar
• Slamon D J, Press M F, Godolphin W. Studies of the HER-2ineu proto-oncogene in human breast cancer. Cancer Cells, M Furth, M Graves. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989; 371–384
   Google Scholar
• Cox D R. Regression models and life tables with discussion. J Roy Statist Soc 1972; B34: 187–192
   Google Scholar
• Harris A L, Nicholson S, Sainsbury R. Epidermal growth factor receptor and other oncogenes as prognostic markers. J Natl Cancer Inst Monogr 1992; 11: 181–187
   PubMedGoogle Scholar
• Svitkina T M, Parsons D F. Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides. Int J Cancer 1993; 55: 1–5
   PubMedGoogle Scholar
• Ghuysen-ltard A-F, Robert L, Jacob M-P. Effet des peptides d'elastine sur la proliferation cellulaire. CR Acad Sci Paris 1992; 315(III)473–478
   PubMedGoogle Scholar
• Gopalakrishna R, Barsky S H. Tumor promotor-induced membrane bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 1988; 85: 612–616
   PubMed Web of Science ®Google Scholar
• Indek Z, Yeh H, Omstein-Goldstein N, Rosenbloom J. Structure of the elastin gene and alternative splicing of elastin mRNA. Extracellular Matrix Genes, LJ Sandell, CD Boyd. Academic Press, New York 1990; 221–250
   Google Scholar
• Seuwen K, Pouyssegur J. G protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res 1992; 58: 75–94
   PubMed Web of Science ®Google Scholar
• Frye R A. lnvolvement of G proteins, cytoplasmic calcium. phospholipases, phospholipid-derived second messengers. and protein kinases in signal transduction from mitogenic cell surface receptors. Oncogenes and Tumor Supressor Genes in Human Malignancies, CC Benz, ET Liu. Kluwer Academic Publishers, Boston 1993; 281–299
   Google Scholar
• Parsons D F. Near-diploid tumor cell lines for cancer research. Cancer Cells 1989; 1: 96–98
   PubMed Web of Science ®Google Scholar
• Wang N P, To H, Lee W-H. Tumor supressor activity of RB and p53 genes in human breast cancer carcinoma cells. Oncogene 1993; 8: 279–288
   PubMed Web of Science ®Google Scholar
• Hamano K, Kinjo M, Kumazawa J. Flow-cytometric DNA analysis of the human bladder cancers with reference to histopathological findings. Eur Urol 1992; 22: 153–157
   PubMed Web of Science ®Google Scholar
• Schimmelpenning H, Eriksson E T, Falkmer U G. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer. Eur J Surg Oncol 1992; 18: 530–537
   PubMedGoogle Scholar
• Herman C J, Duque R E, Hedley D. DNA cytometry in cancer prognosis. Principles Pract Oncol 1993; 7: 1–8
   Google Scholar
• Hunter T. Oncogene products in the cytoplasm: The protein kinases. Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989; 147–173
   Google Scholar
• Fabbro D, Kung W, Costa S D. Involvement of protein kinase C in the growth regulation of human breast cancer cells. Cancer Treat Res 1992; 61: 230–248
   Google Scholar
• Korczak B, Whale C, Kerbel R S. Possible involvement of CJ2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells. Cancer Res 1989; 49: 2597–2602
   PubMed Web of Science ®Google Scholar
• Schwartz O K, Redwood S M, Ohnuma T. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst 1990; 82: 1753–1756
   PubMed Web of Science ®Google Scholar
• De Palazzo I E, Adam G P, Sundareshan P. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 1993; 53: 3217–3220
   PubMed Web of Science ®Google Scholar
• Henry J A, Hennessy C, Levett D L. int-2 amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbB-2 and c-myc. Int J Cancer 1993; 53: 774–780
   PubMed Web of Science ®Google Scholar
• Hendler F J, Shum-siu A, Oechsli M. Increased EGF-RI binding predicts a poor survival in squamous tumors. Cancer Cells, M Furth, M Graves. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989; 347–351
   Google Scholar
• Bernards R, Dessain S K, Weinberg R A. N-myc amplification causes down-modulation of MHC class 1 antigen expression in neuroblastoma. Cell 1987; 47: 667–674
   Web of Science ®Google Scholar
• Mauviel A, Chen Y Q, Kahari V-M. Human recombinant interleukin-1β up-regulates elastin gene expression in dermal fibroblasts. J Biol Chem 1993; 268: 6520–6524
   PubMed Web of Science ®Google Scholar
• Kao R T, Hall J, Stern R. Collagen and elastin synthesis in human stroma and breast carcinoma cell lines: Modulation by the extracellular matrix. Connect Tissue Res 1986; 14: 245–255
   PubMed Web of Science ®Google Scholar
• Krishnan R, Cleary E G. Elastin gene expression in elastotic human breast cancers and epithelial cell lines. Cancer Res 1990; 50: 2164–2171
   PubMed Web of Science ®Google Scholar
• Bressan G M, Daga-Gordini D, Colombatti A. Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface. J Cell Biol 1993; 121: 201–212
   PubMed Web of Science ®Google Scholar
• Hinek A, Wrenn D S, Mecham R P. The elastin receptor: A galactoside-binding protein. Science 1988; 239: 1539–1541
   PubMed Web of Science ®Google Scholar
• Wrenn D S, Hinek A, Mecham R P. Kinetics of receptor-mediated binding of tropoelastin to ligament fibroblasts. J Biol Chem 1988; 263: 2280–2284
   PubMed Web of Science ®Google Scholar
• Grosso L E, Scott M. PGAIPG, a repeated hexapeptide of bovine tropoelastin, is a ligand for the 67-kD bovine elastin receptor. Matrix 1993; 13: 157–164
   PubMedGoogle Scholar
• Morreau H N, Galjert N J, Gillemans N. Alternative splicing of P-galactosidase mRNA generates the classical lysosomal enzyme and a related protein β-galactosidase. J Biol Chem 1989; 264: 20655–20663
   PubMed Web of Science ®Google Scholar
• Hinek A, Rabinovitch M, Keeley F. The 67-kD elas-tin/laminin-binding protein is related to an enzymatically inactive, alternatively sliced form of β-galactosidase. J Clin Invest 1993; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Jacob M-P, Fulop T, Jr, Fork G. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts and smooth muscle cells. Proc Natl Acad Sci USA 1987; 84: 995–999
   PubMed Web of Science ®Google Scholar
• Blood C M, Sasse J, Brodt P. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 1988; 107: 1587–1589
   Google Scholar
• Takenaga K, Takahashi K. Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung colonizing ability of Lewis lung carcinoma cells. Cancer Res 1986; 40: 375–380
   Google Scholar
• Timar J, Lapis K, Fulop T. Interaction between elastin and tumor cell lines of different metastatic potential; in vitro and in vivo studies. J Clin Res Clin Oncol 1991; 117: 232–238
   PubMed Web of Science ®Google Scholar
• Blood C M, Zetter B R. Membrane-bound protein kinase C modulates the receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. J Biol Chem 1989; 264: 10614–10620
   PubMed Web of Science ®Google Scholar
• Mecham R P, Hinek A, Griffin G L. The elastin receptor shows structural and functional similarities to the 67 kD tumor cell laminin receptor. J Biol Chem 1989; 264: 16652–16657
   PubMed Web of Science ®Google Scholar
• Malinoff H L, McCoy JP, Jr, Varani J. Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer 1984; 33: 651–655
   PubMed Web of Science ®Google Scholar
• Campo E, Monteagudo C, Castronovo V. Detection of laminin receptor mRNA in human cancer lines and colorectal tissues by in situ hybridization. Am J Pathol 1992; 141: 1073–1083
   PubMed Web of Science ®Google Scholar
• Kanemoto T, Reich R, Royce L. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc Natl Acad Sci USA 1990; 87: 22379–22383
   Google Scholar
• Mecham R P, Whitehouse M, Hay M. Ligand affinity of 67 kD elastinllaminin binding protein is modulated by the protein's lectin domain: Visualization of elastinilaminin ieceptor complexes with gold-tagged ligands. J Cell Biol 1991; 113: 187–194
   PubMed Web of Science ®Google Scholar
• Mecham R P. The biology of connective tissue: Regulation of mesenchymal cell differentiation by extracellular matrix. Bone Mineral Res 1987; 5: 185–208
   Google Scholar
• Robert L, Jacob M P, Fulop T, Jr. Elastonectin and the elastin receptor. Pathol Biol 1989; 37: 736–741
   PubMed Web of Science ®Google Scholar
• Netland P A, Zetter B R. Melanoma-cell adhesion to defined extracellular matrix components. Biochem Biophys Res Commun 1986; 139: 515–522
   PubMed Web of Science ®Google Scholar
• Mohler J L, Levy F, Sharief Y. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Cancer Res 1991; 51: 6580–6585
   PubMed Web of Science ®Google Scholar
• Groult V, Hornebeck W, Ferrari P. Mechanisms of interaction between human skin fibroblasts and elastin: Differences between elastin fibres and derived peptides. Cell Biochem Function 1991; 9: 171–182
   PubMed Web of Science ®Google Scholar
• McGuire W L, Tandon A K, Allred D C. Treatment decisions in axillary node-negative breast cancer patients. J Natl Cancer Inst Monogr 1992; 11: 173–180
   PubMedGoogle Scholar
• Song M J, Reilly A A, Parsons D F. Patterns of blood vessel invasion by mammary tumor cells. Tissue Cell 1986; 18: 817–825
   PubMed Web of Science ®Google Scholar
• Winstanley J H, Leinster S J, Cooke T G. Prognostic significance of cathepsin D in patients with breast cancer. Br J Cancer 1993; 67: 767–772
   PubMed Web of Science ®Google Scholar
• Cioce V, Castronovo V, Shmookler B M. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 1991; 83: 29–36
   PubMed Web of Science ®Google Scholar
• Kantor J D, McCormick B, Steeg P S. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993; 53: 1971–1973
   PubMed Web of Science ®Google Scholar